- AU$217.65m
- AU$200.61m
- NZ$103.85m
Brief: Aroa Biosurgery Seeks Trading Halt
Australia Stock Exchange release from AROA BIOSURGERY : Release of Shares from Voluntary Escrow
Australia Stock Exchange release from AROA BIOSURGERY : PRE_NR Ends: 10:04:36
Australia Stock Exchange release from AROA BIOSURGERY : June Quarterly Report and Appendix 4C
Australia Stock Exchange release from AROA BIOSURGERY : Notification of cessation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Notification regarding unquoted securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Appendix 3G
Australia Stock Exchange release from AROA BIOSURGERY : Investor Day Presentation
Australia Stock Exchange release from AROA BIOSURGERY : Investor Day - 5 July
Australia Stock Exchange release from AROA BIOSURGERY : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from AROA BIOSURGERY : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from AROA BIOSURGERY : Annual Report to Shareholders
Australia Stock Exchange release from AROA BIOSURGERY : Change of Director's Interest Notice - PM
Australia Stock Exchange release from AROA BIOSURGERY : Application for quotation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Application for quotation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Section 708A Cleansing Statement
Brief: Aroa Biosurgery Posts FY22 Product Sales Guidance Of $30M-33M
Australia Stock Exchange release from AROA BIOSURGERY : PRE_NR Ends: 09:20:49
Australia Stock Exchange release from AROA BIOSURGERY : FY21 Full Year Results Presentation